The cytoprotective effects of dantrolene: a ryanodine receptor antagonist
- PMID: 20861418
- PMCID: PMC9382853
- DOI: 10.1213/ANE.0b013e3181f7181c
The cytoprotective effects of dantrolene: a ryanodine receptor antagonist
Abstract
Calcium, as a second messenger, has an important role in a variety of cellular functions. However, disruption of intracellular calcium homeostasis leads to cytotoxicity and cell death. Excessive calcium release from intracellular stores, via the calcium channel ryanodine receptor, contributes to cell damage. Dysfunction of calcium homeostasis is established in tissue culture and animal models of ischemia, hypoxia, seizure, trauma, anesthesia, and neurodegenerative diseases. Dantrolene, the primary drug to treat malignant hyperthermia, is a ryanodine receptor antagonist. Dantrolene inhibits abnormal calcium release from the sarco-endoplasmic reticulum, which is the primary intracellular calcium store. Dantrolene has been investigated widely for its possible cytoprotective effects against cell damage in different tissue culture or animal models of diseases involving cytotoxicity induced by disruption of intracellular calcium homeostasis in pathogenesis. In this review, we summarize the role of the disruption of intracellular calcium homeostasis on cell death, the pharmacologic and pharmacokinetic features of dantrolene, and the cytoprotective effects and potential application of dantrolene for the inhibition of cell damage in a wide variety of models of stress and disease.
Conflict of interest statement
Disclosure: The authors report no conflicts of interest.
Figures


Similar articles
-
Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons.J Neurosci Res. 2005 Oct 15;82(2):196-205. doi: 10.1002/jnr.20631. J Neurosci Res. 2005. PMID: 16175570
-
A novel target for the promotion of dermal wound healing: Ryanodine receptors.Toxicol Appl Pharmacol. 2019 Mar 1;366:17-24. doi: 10.1016/j.taap.2019.01.021. Epub 2019 Jan 23. Toxicol Appl Pharmacol. 2019. PMID: 30684528
-
Dantrolene Protects Hippocampal Neurons Against Amyloid-β₁₋₄₂-Induced Calcium Dysregulation and Cell Death.Neurochem Res. 2025 Jun 12;50(3):198. doi: 10.1007/s11064-025-04460-5. Neurochem Res. 2025. PMID: 40504441
-
Dantrolene, a treatment for Alzheimer disease?Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):1-5. doi: 10.1097/WAD.0000000000000076. Alzheimer Dis Assoc Disord. 2015. PMID: 25551862 Free PMC article. Review.
-
Dantrolene : From Malignant Hyperthermia to Alzheimer's Disease.CNS Neurol Disord Drug Targets. 2019;18(9):668-676. doi: 10.2174/1871527317666180619162649. CNS Neurol Disord Drug Targets. 2019. PMID: 29921212 Free PMC article. Review.
Cited by
-
Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?Eur Rev Med Pharmacol Sci. 2020 Oct;24(19):10228-10238. doi: 10.26355/eurrev_202010_23247. Eur Rev Med Pharmacol Sci. 2020. PMID: 33090434 Free PMC article.
-
Current clinical application of dantrolene sodium.Anesth Pain Med (Seoul). 2023 Jul;18(3):220-232. doi: 10.17085/apm.22260. Epub 2023 Jul 26. Anesth Pain Med (Seoul). 2023. PMID: 37691593 Free PMC article. Review.
-
Calcium ions trigger the exposure of phosphatidylserine on the surface of necrotic cells.PLoS Genet. 2021 Feb 11;17(2):e1009066. doi: 10.1371/journal.pgen.1009066. eCollection 2021 Feb. PLoS Genet. 2021. PMID: 33571185 Free PMC article.
-
Anesthesia-induced Developmental Neurotoxicity in Pediatric Population.J Surg Res (Houst). 2024;7(4):490-500. doi: 10.26502/jsr.10020400. Epub 2024 Nov 21. J Surg Res (Houst). 2024. PMID: 39687550 Free PMC article.
-
Localization of the dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor.J Biol Chem. 2011 Apr 8;286(14):12202-12. doi: 10.1074/jbc.M110.194316. Epub 2011 Jan 24. J Biol Chem. 2011. PMID: 21262961 Free PMC article.
References
-
- Tsutsumi Y, Yamamoto K, Matsuura S, Hata S, Sakai M, Shirakura K. The treatment of neuroleptic malignant syndrome using dantrolene sodium. Psychiatry Clin Neurosci 1998;52: 433–8 - PubMed
-
- Dykes MH. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium). JAMA 1975;231:862–4 - PubMed
-
- Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene: a review of its pharmacology, therapeutic use and new developments. Anaesthesia 2004;59:364–73 - PubMed
-
- Hall AP, Henry JA. Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 2006;96:678–85 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources